AU2002214320A1 - Imidazole derivatives, process for their preparation and their use - Google Patents

Imidazole derivatives, process for their preparation and their use

Info

Publication number
AU2002214320A1
AU2002214320A1 AU2002214320A AU1432002A AU2002214320A1 AU 2002214320 A1 AU2002214320 A1 AU 2002214320A1 AU 2002214320 A AU2002214320 A AU 2002214320A AU 1432002 A AU1432002 A AU 1432002A AU 2002214320 A1 AU2002214320 A1 AU 2002214320A1
Authority
AU
Australia
Prior art keywords
ring
chem
preparation
alkyl group
membered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002214320A
Inventor
Masami Kusaka
Nobuyuki Matsunaga
Akio Ojida
Akihiro Tasaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2002214320A1 publication Critical patent/AU2002214320A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The present invention provides a compound having a steroid C17,20-lyase inhibitory activity, which is useful as a prophylactic or therapeutic agent of prostatism and tumor such as breast cancer and the like. <??>A compound represented by the formula: <CHEM> or <CHEM> wherein R is a hydrogen atom or a protecting group, R<1> is a lower alkyl group or a cyclic alkyl group, and ring A and ring B are each an optionally substituted 5-membered or 6-membered ring having an amide bond in the ring, or a salt thereof.
AU2002214320A 2000-11-20 2001-11-19 Imidazole derivatives, process for their preparation and their use Abandoned AU2002214320A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000353634 2000-11-20
JP2000382056 2000-12-15
JP2000-353634 2000-12-15
JP2000-382056 2000-12-15
PCT/JP2001/010079 WO2002040470A1 (en) 2000-11-20 2001-11-19 Imidazole derivatives, process for their preparation and their use

Publications (1)

Publication Number Publication Date
AU2002214320A1 true AU2002214320A1 (en) 2002-05-27

Family

ID=26604319

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002214320A Abandoned AU2002214320A1 (en) 2000-11-20 2001-11-19 Imidazole derivatives, process for their preparation and their use

Country Status (7)

Country Link
US (1) US6960586B2 (en)
EP (1) EP1344777B1 (en)
AT (1) ATE502030T1 (en)
AU (1) AU2002214320A1 (en)
CA (1) CA2429437A1 (en)
DE (1) DE60144246D1 (en)
WO (1) WO2002040470A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004035566A1 (en) * 2002-10-18 2004-04-29 Pfizer Products Inc. Cannabinoid receptor ligands and uses thereof
EP1830845A2 (en) * 2004-11-09 2007-09-12 Shering Corporation Improved dosing regimen of temozolomide for treating cancer based on the patient's mgmt level
US20070111979A1 (en) * 2005-11-07 2007-05-17 Walter Robert Bishop Methods of treating cell proliferative disorders using a compressed temozolomide dosing schedule
WO2007146136A2 (en) * 2006-06-12 2007-12-21 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
CA2686848A1 (en) * 2007-05-08 2008-11-20 Schering Corporation Methods of treatment using intravenous formulations comprising temozolomide
US8180029B2 (en) 2007-06-28 2012-05-15 Voxer Ip Llc Telecommunication and multimedia management method and apparatus
EP2588104B1 (en) * 2010-07-01 2014-12-10 Merck Sharp & Dohme Corp. Isoindolone m1 receptor positive allosteric modulators

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221729A (en) 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
ZA882717B (en) 1987-04-22 1988-10-17 Merrell Dow Pharmaceuticals Inc. 17beta-(cyclopropylamino)-androst-5-eb-3beta-ol and related compounds useful as c17-20 lyase inhibitors
US4966898A (en) 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
WO1992015604A1 (en) 1991-02-27 1992-09-17 New York University Anti-testosterone compounds and method of use thereof
ATE174817T1 (en) 1991-03-01 1999-01-15 Electrostatic Technology Inc POWDER COATING PROCESS FOR THE PRODUCTION OF CIRCUIT BOARDS AND SIMILAR
US5457102A (en) * 1994-07-07 1995-10-10 Janssen Pharmaceutica, N.V. Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives
GB2265624B (en) 1992-03-31 1995-04-19 British Tech Group 17-substituted steroids useful in cancer treatment
GB9310635D0 (en) 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
WO1995009157A1 (en) 1993-09-30 1995-04-06 Yamanouchi Pharmaceutical Co., Ltd. Azole derivative and pharmaceutical composition thereof
AU3846395A (en) 1994-11-07 1996-05-31 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
WO1997000257A1 (en) 1995-06-14 1997-01-03 Yamanouchi Pharmaceutical Co., Ltd. Fused imidazole derivatives and medicinal composition thereof
US6420375B1 (en) 1997-02-21 2002-07-16 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
ATE264304T1 (en) 1997-10-02 2004-04-15 Daiichi Seiyaku Co DIHYDRONAPHTHALINE DERIVATIVES AND METHOD FOR PRODUCING THE SAME
DE69924717T2 (en) * 1998-04-23 2006-03-09 Takeda Pharmaceutical Co. Ltd. Naphthalenic derivatives, their preparation and their use
CA2388483A1 (en) * 1999-10-22 2001-05-03 Takeda Chemical Industries, Ltd. Process for producing optically active naphthalene derivative and optical resolver therefor
PE20010781A1 (en) * 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd COMPOUNDS 1- (1H-IMIDAZOL-4-IL) -1- (NAFTIL-2-SUBSTITUTED) ETHANOL, ITS PRODUCTION AND USE
CA2388508A1 (en) * 1999-10-22 2001-05-03 Takeda Chemical Industries, Ltd. 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof

Also Published As

Publication number Publication date
US6960586B2 (en) 2005-11-01
US20040024039A1 (en) 2004-02-05
CA2429437A1 (en) 2002-05-23
EP1344777B1 (en) 2011-03-16
WO2002040470A1 (en) 2002-05-23
ATE502030T1 (en) 2011-04-15
EP1344777A1 (en) 2003-09-17
DE60144246D1 (en) 2011-04-28
EP1344777A4 (en) 2007-05-09

Similar Documents

Publication Publication Date Title
EP1652847A3 (en) Quinoline and quinazoline derivatives for the treatment of tumors
DE69831868D1 (en) Antithrombosemittel
EP1070710A3 (en) Dithiolan derivatives, their preparation and their therapeutic effect
SI1678166T1 (en) Protein kinase inhibitors
BG106585A (en) Kinase inhibitors as therapeutic agents
WO2002072009A3 (en) Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
GB9914486D0 (en) Medicaments
AU2002246728A1 (en) Carboline derivatives
EP1348706A4 (en) Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
AU2002249890A1 (en) Carboline derivatives
BR0213464A (en) 3-Azabicyclo [3.1.0] hexane derivatives as opioid receptor antagonists
AU2002213421A1 (en) Condensed pyridoindole derivatives
AU4023093A (en) Novel substituted tertiary amino compound or salt thereof
PL359415A1 (en) Oxadiazole derivatives having anticancer effects
AU2002214320A1 (en) Imidazole derivatives, process for their preparation and their use
AU7950100A (en) 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof
YU76500A (en) Chemical synthesis of morpholine derivatives
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
DE60000978D1 (en) 22R-HYDROXYCHOLESTA-8,14-DIENE DERIVATIVES FOR INHIBITING MEIOSE
GC0000218A (en) New imidazole derivatives
WO2003076426A3 (en) Pyridinyloxy derivatives as 5-ht receptor ligands
MXPA05014127A (en) Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions.
IL149620A0 (en) 5-D-β-THIOXYLOSE DERIVATIVES, PREPARATION METHOD AND THERAPEUTIC USE
HUP9801327A2 (en) Use of benzotiophene derivatives for production of medicaments inhibiting ovarian cancer
DE69528984T2 (en) INHIBITION OF LEUKOTRIA BIOSYNTHESIS BY URINE DERIVATIVES